Opinion on Ibrutinib on 1st Line CLL

Opinion on Ibrutinib on 1st Line CLL
Don Photo

Don
3 years 206 Views
Category:
Description:
Paul M. Barr MD Associate Professor of Medicine at Wilmot Cancer Institute provides his opinion on ibrutinib in 1st line chronic lymphocytic leukemia (CLL).